Date of SOH Approval: 10 October 2022 Pursuant to the role of the Health Technology Assessment Council (HTAC) to develop coverage recommendations particularly in the selection and financing of COVID-19 vaccines using the Evaluation Framework set by the HTAC, this report presents all currently available evidence considered in the assessment of CoronaVac COVID-19 Vaccine for children continue reading : CoronaVac COVID-19 Vaccine for Children 6 to 17 Years Old
HTAC Preliminary Recommendation on Abiraterone Acetate (250mg Tablet) and Enzalutamide (40mg Soft Gel Capsule)
Link to evidence summary Publication date: 04 October 2022 (Stakeholders may submit appeals to hta@doh.gov.ph until 18 October 2022 using the prescribe form found here: Topic Nomination ) Document Preview:
Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus
On 10 October 2022, the OIC-Secretary of Health (SOH) approved the Health Technology Assessment Council (HTAC) recommendation for the government financing of both insulin glargine 10mL vial (100 IU/ml) and 3mL pre-filled pen (100 IU/ml) for patients with type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) through their inclusion in the Philippine National Formulary (PNF). In continue reading : Insulin Glargine and Insulin Detemir for Type 1 and Type 2 Diabetes Mellitus
Evidence brief for 17 to 23 September 2022
For the period of 17 to 23 September 2022 Reviewed by: Department of Health (DOH) – Health Technology Assessment Division (HTAD) Document Link: 17– 23 September 2022 Document Preview: